395
Views
6
CrossRef citations to date
0
Altmetric
Review

The safety of pharmacological treatment options for lupus nephritis

, &
Pages 1041-1054 | Received 11 Mar 2016, Accepted 21 Apr 2016, Published online: 13 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mario E Alamilla-Sanchez, Miguel A Alcala-Salgado, Cesar D Alonso-Bello & Gandhy T Fonseca-Gonzalez. (2021) Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis. International Journal of Nephrology and Renovascular Disease 14, pages 441-458.
Read now

Articles from other publishers (5)

Clara Moriano, David Bellido Pastrana, Carmen San Román Gutiérrez & Eva Rodríguez. (2023) Evolución del diagnóstico y tratamiento de la nefritis lúpica en España. Nefrología 43:6, pages 668-675.
Crossref
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D. Poole, Daniela Baracaldo-Santamaría & Claudia M. Tellez Freitas. (2022) Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. Medicina 59:1, pages 56.
Crossref
Amy J. Petty, Lauren Floyd, Christopher Henderson & Matilda W. Nicholas. (2020) Cutaneous Lupus Erythematosus: Progress and Challenges. Current Allergy and Asthma Reports 20:5.
Crossref
Laura Barcia‐Sixto & David Isenberg. (2020) Systemic lupus erythematosus: causes and manifestations. Trends in Urology & Men's Health 11:1, pages 26-29.
Crossref
Evaldas Tytmonas, Artūras Vinikovas, Ernesta Mačionienė, Marius Miglinas & Laurynas Rimševičius. (2017) GLOMERULONEFRITŲ IMUNOSUPRESINIO GYDYMO KOMPLIKACIJOS. Medicinos teorija ir praktika 22:3, pages 233-238.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.